Clinical trial
Sedation Faisability by Inhalation of Kalinox 170 Bar During Therapeutic Cares in Primary Care Dental Centers
NCT00643838 is registered in ClinicalTrials.gov with Air Liquide Santé International as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sedation Faisability by Inhalation of Kalinox 170 Bar During Therapeutic Cares in Primary Care Dental Centers
- Lead sponsor
- Air Liquide Santé International
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 2007
- Completion date
- July 31, 2008
- Enrollment
- 549 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dental cares